SuperQ enters commercial deal with Science & Humans

Dr. Muhammad Khan reports SUPERQ QUANTUM ENTERS COMMERCIAL AGREEMENT TO DEPLOY QUANTUM-AI CLINICIAN SYSTEMS FOR SCIENCE & HUMANS SuperQ Quantum Computing Inc. has entered into a commercial agreement with Science & Humans, a Canadian hormonal health company and a recipient of the Deloitte Technology Fast 50 recognition in 2025, to deploy quantum-artificial-intelligence-powered clinician solutions for S&H. Under the agreement, SuperQ will architect and deliver AI clinicians enhanced by quantum-computing-based optimization for S&H to integrate into its real-world health care workflows. Addressing challenges of increased clinical demands S&H is an Ontario-based provider of hormonal health care including menopause, thyroid conditions, sexual health and more. It has been experiencing significant user growth and is one of the Deloitte's Technology Fast 50 companies this year. S&H requires autonomous systems such as diagnostic and treatment AI to keep up with the increased demand. High accuracy and speed are key considerations for this sensitive life science use case. S&H's scientific and clinical teams are providing the domain expertise and knowledge base for these systems. SuperQ is building these systems for S&H through its professional services and Super platform, which enables development of quantum-AI products. Super implements interoperability across quantum hardware types (annealing, gate based and hybrid classical/quantum) and integrates high performance classical compute, AI-driven orchestration and quantum processing. This gateway approach enables enterprises and health care institutions to leverage emerging quantum architectures along with GPU-based AI pipelines without being locked into a single hardware ecosystem. Aftab Pashaw, chief executive officer of S&H, commented: "We are excited to be the first to explore frontier AI and quantum technologies in clinical diagnosis and treatment. SuperQ is playing a key role in the development, integration and enhancement of our clinical AI systems. Together, we have already reached the MVP stage and aim to reach full production in the coming months." Strategic implications in the backdrop of Nvidia announcements The recent unveiling of Nvidia's NVQLink interconnect at Nvidia GTC DC marks a pivotal shift in how quantum and classical compute infrastructure will collaborate, a shift that directly amplifies the strategic value of SuperQ's Super platform. Nvidia is now doing at the hardware level what SuperQ has been doing at the software level -- interlacing classical and quantum computing to create real-world value. The Quantum, AI and high performance computing: intersection opportunities meetup organized by Dr. Khan at the Nvidia GTC explored this coupling in detail. The participants agreed that it has entered a hybrid classical-quantum reality. Nvidia's hardware announcements reinforce SuperQ's vision of driving commercial value from hybrid compute. Super gateway platform is purpose built to orchestrate classical compute, AI pipelines and multiple quantum hardware types (annealing, gate based and hybrid), especially in sensitive industries like health care, where reliability, interpretability and speed are non-negotiable. "Commercial use cases for the Super platform and related professional services are growing by the day," said Dr. Muhammad Khan, chief executive officer and board chair of SuperQ. "The Science & Humans project signals that quantum AI is now ready to transform clinician workflows, where the margin for error is minimal and the stakes are highest." Project highlights SuperQ will architect and deliver quantum-AI clinician systems in domains where accuracy, interpretability and reliability are paramount -- including patient triage, autonomous monitoring, treatment optimization and decision support in sensitive care environments. The initial road map entails a phased-deployment approach: Triaging patients and enhancing diagnostic decision support; Streamlining prescription workflows; Extending into chronic disease management, real-time patient monitoring and broader health care system logistics. Science & Humans brings recognized clinical and scientific domain strength to the collaboration. Notably, Science & Humans was ranked No. 32 on Deloitte Canada's 2025 Technology Fast 50 list, reflecting 970-per-cent growth over the prior three years. This agreement complements SuperQ's recent hardware-and-software road map expansion, including the launch of its Super hybrid quantum-classical platform and the initiation of quantum-hardware development -- positioning SuperQ as one of the few, if not the first, bridging quantum AI architecture with commercial health care solutions. About SuperQ Quantum Computing Inc. SuperQ is defining the next era of enterprise transformation, looking to emerge as a partner for global organizations seeking direct quantum and supercomputing return on investment previously beyond reach. It is looking to position itself as the trusted leader in quantum and supercomputing-powered problem solving and optimization. Its flagship Super platform strives to make the most advanced computational power intuitive and accessible. This will empower executives, leading research institutions and critical government agencies to unlock immediate business impact across finance, health care, logistics, defence and beyond, leveraging its proprietary AI autopilots to turn complex challenges into executive-ready results with one-click productization and deployment. SuperQ Quantum is headquartered in Canada with a growing international presence, particularly in the United States, Middle East and Asia, strategically establishing Super hubs in key regions. We seek Safe Harbor.